Andrew Exley
Impact in
- Rheumatology top 2%
- Otitis Media and Relapsing Polychondritis
- Systemic Lupus Erythematosus Research
- Urticaria and Related Conditions
-
- Vasculitis and related conditions
- Pulmonary Hypertension Research and Treatments
Papers in
- Immunology 15
- Immunodeficiency and Autoimmune Disorders 6
- Atherosclerosis and Cardiovascular Diseases 3
Andrew Exley
44 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 100
- Rheumatology 596
- Pulmonary and Respiratory Medicine 1.2k
- Immunology 634
- Genetics 296
- Nephrology 119
Countries citing papers authored by Andrew Exley
This map shows the geographic impact of Andrew Exley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Exley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Exley more than expected).
Fields of papers citing papers by Andrew Exley
This network shows the impact of papers produced by Andrew Exley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Exley. The network helps show where Andrew Exley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Exley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2020 | 6 | |
| 3 | 2020 | 39 | |
| 4 | 2011 | 26 | |
| 5 | 2009 | 1 | |
| 6 | 2009 | 174 | |
| 7 | 2008 | 26 | |
| 8 | 2006 | 123 | |
| 9 | 2005 | 1 | |
| 10 | 1999 | 11 | |
| 11 | 1999 | 91 | |
| 12 | 1997 | 91 | |
| 13 | Vasculitis integrated total assessment log (VITAL): A system for clinical evaluation of vasculitis. | 1996 | 6 |
| 14 | Functional outcome vs damage in systemic vasculitis | 1996 | 3 |
| 15 | 1996 | 7 | |
| 16 | THE VASCULITIS DAMAGE INDEX (VDI) | 1995 | 3 |
| 17 | FUNCTIONAL ASSESSMENT IN VASCULITIS USING THE SF-36 | 1995 | 1 |
| 18 | 1992 | 181 | |
| 19 | 1990 | 32 | |
| 20 | 1989 | 9 |
About Andrew Exley
Andrew Exley is a scholar working on Microbiology, Immunology, Pulmonary and Respiratory Medicine, Genetics and Physiology, having authored 46 papers that have together received 2.3k indexed citations. Recurring topics across this work include Vasculitis and related conditions (12 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), DNA Repair Mechanisms (3 papers), Cystic Fibrosis Research Advances (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). The work is most often cited by research in Rheumatology (596 citations), Pulmonary and Respiratory Medicine (1.2k citations), Immunology (634 citations), Genetics (296 citations) and Nephrology (119 citations). Andrew Exley has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include P A Bacon, Raashid Luqmani, George D. Kitas, Caroline Gordon, Caroline O. S. Savage, Dwomoa Adu, J. Cohen, T Leese, Mark Holliday and R A Swann. Their work appears in journals such as Clinical Immunology, Circulation, QJM, Lara D. Veeken and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.